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Dear Editor: 
The European Centre for Disease Prevention and Control reported that there were 2896 acute 
hepatitis B cases in 24 EU/EEA countries in 2013.1 The incidence ranged from 0.1 cases per 
100,000 in France and Portugal to 4.3 per 100,000 in Latvia, with a male-to-female ratio of 
2.2:1 in EU/EEA countries, and transmission among men who have sex with men (MSM) 
reported in 9.4% of all cases of acute hepatitis B.1 Some authors consider hepatitis B virus 
(HBV) infection to be endemic in the MSM population with the incidence 20 times higher in 
MSM than in the general population worldwide.2 However, data on HBV prevalence among 
MSM are available for only four EU/EEA countries.3  Six to ten percent of MSM infected 
with HBV worldwide are co-infected with HIV.4 
In AP Vojvodina, no cases of acute hepatitis B among MSM were reported from 2000 to 
2009. According to active hepatitis B surveillance data from the Institute of Public Health of 
Vojvodina, during this time the average yearly incidence of acute hepatitis B was 3.9 per 
100,000 in the general population (Table 1).5 As it is the responsibility of a patient with HBV 
to declare their potential exposures, it is possible that some MSM with HBV did not report 
their sexual risk behavior.  Nevertheless, among MSM who were tested for HBV and did 
report their sexual risk behavior, none were HBV positive (neither acute nor chronic 
infection).  Eight hundred and one cases of acute hepatitis B were reported during this period 
with a male/female incidence rate ratio of 1.5. 
In June 2011, an agglomeration of acute hepatitis B in MSM was observed. The case 
definition for acute hepatitis B included onset of any sign or symptom consistent with acute 
viral hepatitis and either jaundice or elevated serum alanine aminotransferase (ALT) levels 
>100 IU/L and detection of hepatitis B surface antigen (HBsAg) in serum or absence of 
symptoms and detection of HBsAg in serum with a documented negative HBsAg test result 
within six months prior to a positive test. After retrospective analysis and active 
4 
 
epidemiological investigation, 30 acute hepatitis B cases in MSM were identified, with the 
first case identified in January 2010 retrospectively. By the end of October 2012, thirty-one 
other cases of acute hepatitis B among MSM had been identified. This was the first outbreak 
recognized in the MSM population in Serbia. According to the Serbian “Law on Protection of 
Population from Communicable Diseases”,6 an outbreak is defined as “an occurrence of a 
communicable disease unusual by the number of cases, time, place and population affected, 
or unusual increase in the number of patients with complications or death, as well as the 
occurrence of two or more interrelated cases of communicable disease that never occurred in 
one area or an occurrence of several cases of diseases whose cause is unknown and is 
accompanied by a fever condition”.  
Sexual behavior was assessed based on self-reporting during the anamnesis as per routine. It 
is possible, however, that both patients and physicians had become more open to talking 
about sexual behavior than they were previously due to efforts to create a clinical atmosphere 
more conducive to disclosure of sexual orientation. Nevertheless, in MSM-friendly testing 
sites no cases of acute had been identified during the previous decade. As more than half 
(61/118) of the acute hepatitis B infections identified in men during 2010-2012 were among 
MSM, we believe that these hepatitis B infections among MSM reflect an outbreak, not just 
an increase in disclosure. 
The median age of the MSM with hepatitis B was 28, with an age range of 19-52. Students 
comprised 33% of all cases. Almost all of the MSM (97%) had not been vaccinated against 
HBV.  Genotype information was available for 11 cases. All but one of the MSM were 
infected with an identical genotype A strain with subtype adw2. One genotype D isolate with 
the D3 sub-genotype was isolated. Genotype A, which was predominant in this sample of 
MSM in AP Vojvodina, has also been found to be predominant in the MSM population 
across Europe and in MSM worldwide.2 On the contrary, genotype D is the most common 
5 
 
genotype in the general population in Eastern Europe and Eastern Mediterranean countries, as 
well as in Serbia.7 
Several measures were introduced with the aim of controlling the outbreak among MSM in 
AP Vojvodina. A voluntary counselling and testing (VCT) site was established in a drop-in 
center for MSM in Novi Sad, where all clients were counselled about the prevention of 
hepatitis B and vaccination against HBV was recommended. In other existing VCT centers, 
counsellors were sensitized to offer HBV testing and vaccination to MSM. In addition, 
testing and vaccination (if negative) were recommended to the sexual partners of those who 
tested positive. 
In a country where the MSM population is still much stigmatized, implementation of broad 
preventive programs is difficult. The Republic of Serbia adopted the Law on the Prohibition 
of Discrimination8 in 2009 and the Strategy for Prevention and Protection Against 
Discrimination9 in 2013, which state explicitly that sexual orientation is a private matter and 
that no one can be invited to disclose their sexual orientation, but anyone has the right to 
disclose their sexual orientation. Discrimination due to disclosure is prohibited and 
discrimination based on sexual orientation is considered as a severe case of discrimination. 
However, the penalties for discrimination are low (US$45-850).  
A law on patients’ rights10 from 2013 states that “a patient has the right to the confidentiality 
of all personal information that he has communicated to the competent healthcare 
professional or healthcare associate, including those related to his state of health and potential 
diagnostic and therapeutic procedures, as well as the right to protection of his privacy during 
the conduct of diagnostic testing and treatment in whole” and it prohibits healthcare workers 
from informing other people about the patients’ personal information. However, the LGBT 
population in Serbia remains highly stigmatized with almost half of the population 
considering homosexuality to be an illness and 80% reporting that they would not accept an 
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LGBT person in their family.11 Some of the factors that contribute to existing stereotypes and 
prejudices about LGBT populations and promote heterosexuality only as desirable are 
churches, conservative nationalistic political parties, right-wing movements, and some public 
institutions (health institutions, police, etc).12  
Advocacy is needed to reduce the risk of hepatitis B in the MSM population. This advocacy 
should be directed toward the general population as well as physicians and decision makers in 
order to reduce stigmatization of the MSM population, and to provide information about 
vaccination, as well as the risks, consequences, and prevention of sexually transmitted 
infections (STIs).  MSM-friendly confidential and anonymous health services should be 
promoted with the aim of increasing HBV screening and vaccination in MSM. Routine 
hepatitis B immunization for children (newborns and 12 years old) in Serbia was introduced 
in 2005 and so it didn’t cover the population affected by the outbreak. According to the 2006 
Bylaw on Immunization and Chemoprophylaxis13 some other populations are also covered by 
hepatitis B vaccination, such as people with hemophilia, patients on hemodialysis, and people 
who inject drugs, but not MSM. We recommend that hepatitis B vaccination for MSM is 
included in immunization programs and campaigns in Serbia. 
Effective harm reduction strategies for reducing transmission of hepatitis B and other STIs 
exist including immunization, counseling, testing, and early diagnosis and treatment.  Failure 
of MSM to disclose their risk behaviors could delay diagnosis and treatment and, therefore, 
increase transmission. The promotion of VCT services, based on MSM-friendly health 
services that provide a safe environment in which to disclose same-sex behavior, has resulted 
in MSM being diagnosed and referred for treatment earlier compared to other HIV cases.14 
Following the HIV example, health services, particularly in those countries where MSM are 
highly stigmatized, should be supported in developing MSM-friendly services conducive to 
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disclosure. Such services would greatly increase the effectiveness of efforts to identify, treat, 
and decrease the transmission of hepatitis B and other STIs.  
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